Lortab and Visual field defect - a phase IV clinical study of FDA data

Summary:

Visual field defect is reported as a side effect among people who take Lortab (acetaminophen; hydrocodone bitartrate), especially for people who are female, 30-39 old, also take Duragesic-100, and have Breakthrough pain.

The phase IV clinical study analyzes which people have Visual field defect when taking Lortab. It is created by eHealthMe based on reports of 29,547 people who have side effects when taking Lortab from the FDA, and is updated regularly.

What is Lortab?

Lortab has active ingredients of acetaminophen; hydrocodone bitartrate. It is often used in pain. eHealthMe is studying from 31,285 Lortab users. Check the latest studies of Lortab.

What is Visual field defect?

Visual field defect is found to be associated with 769 drugs and 1,037 conditions by eHealthMe. Check the latest studies of Visual field defect.

On Jul, 07, 2026

29,547 people reported to have side effects when taking Lortab.
Among them, 33 people (0.11%) have Visual field defect.

Among these 33 people:

What is the gender of people who have Visual field defect when taking Lortab? *

female: 51.52 %
male: 48.48 %

What is the age of people who have Visual field defect when taking Lortab? *

What are other drugs people take besides Lortab? *

What are other side effects people have besides Visual field defect? *

Memory Loss: 20 people, 60.61%
Headache (pain in head): 17 people, 51.52%
Stress And Anxiety: 16 people, 48.48%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 16 people, 48.48%
Tremor (trembling or shaking movements in one or more parts of your body): 15 people, 45.45%
Weakness: 15 people, 45.45%
Weight Decreased: 14 people, 42.42%
Insomnia (sleeplessness): 13 people, 39.39%
Nausea (feeling of having an urge to vomit): 13 people, 39.39%
Disturbance In Attention: 13 people, 39.39%

What are the existing conditions these people have? *

Breakthrough Pain: 10 people, 30.30%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 9.09%
Acne (skin problems that cause pimples): 2 people, 6.06%
Sleep Disorder: 2 people, 6.06%
Migraine (headache): 2 people, 6.06%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 6.06%
Erection Problems: 1 person, 3.03%
High Blood Cholesterol: 1 person, 3.03%
Heart Rate Irregular: 1 person, 3.03%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Lortab and have Visual field defect?

- Check whether Visual field defect is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lortab:

Lortab (31,285 reports)

Visual field defect treatments and more:

Visual field defect (8,900 reports)

How severe was Visual field defect and when was it recovered:

Visual field defect in Lortab

Expand to all the drugs that have ingredients of acetaminophen; hydrocodone bitartrate:

Visual field defect and drugs with ingredients of acetaminophen; hydrocodone bitartrate (141 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lortab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual field defect:

Visual field defect (769 drugs)

Browse all the conditions that are associated with Visual field defect:

Visual field defect (1,037 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; hydrocodone bitartrate (the active ingredients of Lortab) and Lortab (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.